Related Experiment Video

Updated: Jun 2, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer

Hui Chen1, Lili Chen, Lingyu Sun

  • 1Department of General Surgery, Third Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.

Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|May 4, 2011
PubMed
Abstract

Insights

The Kruppel-like factor 6 splice variant 1 (KLF6-SV1) promotes gastric cancer growth and spread. Inhibiting KLF6-SV1 with small interfering RNA (siRNA) suppressed tumor progression and offers a potential gene therapy for gastric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • The tumor suppressor gene Kruppel-like factor 6 (KLF6) and its splice form KLF6-SV1 are implicated in cancer development and progression.
  • The specific role of KLF6-SV1 in gastric cancer pathogenesis remains largely undetermined.

Purpose of the Study:

  • To investigate the role of KLF6-SV1 in gastric cancer.
  • To evaluate the therapeutic potential of downregulating KLF6-SV1 in gastric cancer models.

Main Methods:

  • KLF6-SV1 expression was assessed in gastric cancer cell lines and patient samples using RT-PCR and Western blotting.
  • Small interfering RNA (siRNA) was employed to inhibit KLF6-SV1 in gastric cancer cell lines (BGC-823, SGC-7901).
  • Effects on cell proliferation, migration, invasion, apoptosis, and tumor growth in vitro and in vivo were examined.

Main Results:

  • KLF6-SV1 was overexpressed in gastric tumors and cell lines.
  • siRNA-mediated KLF6-SV1 downregulation inhibited cell proliferation, migration, invasion, and anchorage-independent growth.
  • KLF6-SV1 silencing promoted apoptosis and suppressed tumor growth and tumorigenicity in vivo, with gene therapy showing efficacy in a xenograft model.

Conclusions:

  • KLF6-SV1 is a key regulator of gastric cancer cell growth, migration, invasion, and survival.
  • Downregulation of KLF6-SV1 via siRNA presents a promising gene therapy strategy for gastric cancer treatment.

More Related Videos

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...